|drug1041||Discussion Board for Social Support +Basic Feedback Wiki||1.00|
|drug1042||Discussion Board for Social Support+Personalized Feedback Wiki||1.00|
|drug3543||Video Chat + Basic Feedback Wiki||1.00|
There is one clinical trial.
The current pilot study will explore the optimal cost-effective treatment configuration for online group-based weight control by focusing on two aspects of our existing treatment program which have significant associated cost and determine which contribute meaningfully to weight loss outcomes. Specifically, we will explore whether adding synchronous group social support (weekly group video chat sessions facilitated by a trained weight loss counselor) to on demand (asynchronous) social support provided through the program discussion board significantly increases weight losses achieved. We will also examine whether detailed feedback on dietary and physical activity self-monitoring records from a counselor enhances weight loss outcomes in comparison with basic feedback. Finally, we will examine the cost efficiency of the treatment constellations. Further, this pilot study will also explore the feasibility of recruiting participants nationally (rather than just locally) and the capture of data electronically (including body weight measurements) without any in-person contact.
Description: Change in body weight from baseline calculated as kg lostMeasure: Weight loss Time: Baseline, 2 and 4 months
Description: 1 - [follow-up body weight/ baseline body weight] = % body weight changeMeasure: Change in body weight from baseline calculated as % of body weight lost Time: 2 and 4 months
Description: Self-monitoring rates for daily weighing and will be calculated as the total number of days of weight submitted over the 4 month period divided by the total number of days of potential self-weighing.Measure: Treatment Engagement: daily weighing Time: Weeks 1 to 16
Description: Self-monitoring rates for daily dietary self monitoring will be calculated as the total number of weeks of digital food diaries submitted over the 4 month period divided by the total number of weeks of potential digital diary submissions.Measure: Treatment Engagement: weekly food journal submissions Time: Weeks 1 to 16
Description: Percent of weekly module completion will be calculated as the total number of weeks of completed modules submitted over the 4 month period divided by 16 (the total number of modules available).Measure: Treatment Engagement: completion of the 16 weekly interactive online modules Time: Weeks 1 to 16
Description: Percent of weekly video chat attendance will be calculated as the total number of weeks each participant attended video chat over the 4 month period divided by 16 (the total number of video chats available).- Collected only for those randomized to a condition with video chatMeasure: Treatment Engagement: Attendance at Video Chat condition Time: Weeks 1 to 16
Description: All participants will be administered the Supportive Accountability Questionnaire to determine whether there is a difference in accountability experienced by participants depending on which intervention they receive.Measure: Supportive Accountability Time: 2 months and 4 months
Description: All participants will be administered the Perceived Social Support Scale to determine whether perceptions of social support differ depending on which intervention participants receive.Measure: Social Support Time: baseline, 2 months and 4 months
Description: Actual counselor time spent in delivering group video chats and giving feedback will be tracked in order to quantify the relative costs of delivering behavioral weight control programs.Measure: Cost-Effectiveness Analyses Time: Weeks 1 to 16
Description: All participants will be queried as to their expectations and preferences in treatment prior to intervention.using a measure designed for the current studyMeasure: Treatment Expectations Time: Baseline
Description: Each month participants will be asked to complete a survey inquiring about the helpfulness of the treatment modules, skills building assignments, and satisfaction with their treatment experiences in the previous month. Response options will be a 5-point Likert scale with 1=not at all helpful/useful and 5=extremely helpful/useful on a measure that is developed for this study and tailored to the treatment elements provided.Measure: Treatment Satisfaction Time: through study completion, up to 24 weeks
Description: Participants self report on their self management behaviorsMeasure: Self Regulation Questionnaire Time: baseline
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports